X
28Jun

[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action

Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By: Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/

Related

Beyond Brexit transition - Continued uncertainty for construction projects

There is no change in the two key issues that have been causing concern to those involved in real es...

Read More >

Bama Legislators Say Nay to Unfair Pay

Alabama passed the Clarke-Figures Equal Pay Act which will go into effect in August, making Alabama ...

Read More >

Staying Healthy: IRS Expands HDHP-HSA Preventive Care Benefits For Chronic Conditions

A Health Savings Account (HSA) is a popular vehicle for paying health care costs. Employees find HSA...

Read More >

The Coronavirus: FAQs for Employers

We’ve been here before. Remember the H1N1 outbreak of 2009? That little bug originated outside of M...

Read More >

Nuclear Power Company Avoids ADA Discrimination Claim Meltdown

Seyfarth Synopsis: In Flaherty v. Entergy Nuclear Operations, Inc., ___ F.3d ___, No. 18-1759, 2019 ...

Read More >

Public Health vs. Patient Privacy – How Coronavirus is Putting HIPAA to the Test

In a recent blog post, colleagues in our Employment, Labor & Workforce Management practice addressed...

Read More >